(FM) Oncología
Departamento académico
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria de Navarra (117)
2024
-
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/ MINOVA Study)
Clinical Cancer Research, Vol. 30, Núm. 1, pp. 176-186
-
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-priming
Immunological Reviews, Vol. 321, Núm. 1, pp. 143-151
-
Dendritic Cells in Cancer Immunology and Immunotherapy
Cancers, Vol. 16, Núm. 5
-
Radiotherapy protocols for mouse cancer model
Methods in Cell Biology (Academic Press Inc.), pp. 99-113
-
Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis
British Journal of Surgery, Vol. 111, Núm. 2
-
The ELECLA trial: A multicentre randomised control trial on outcomes of neoadjuvant treatment on locally advanced colon cancer
Colorectal Disease, Vol. 26, Núm. 4, pp. 745-753
-
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Molecular Cancer, Vol. 23, Núm. 1
-
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
eBioMedicine, Vol. 102
2023
-
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
Frontiers in Immunology, Vol. 14
-
A pharmacometrics model to define docetaxel target in early breast cancer
British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736
-
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects
Science advances, Vol. 9, Núm. 33, pp. eadf6692
-
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary
Cancer discovery, Vol. 13, Núm. 3, pp. 552-569
-
Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic adenocarcinoma
Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 428-434
-
Druggable Targets in Cytokine Release Syndromes
Clinical Cancer Research, Vol. 29, Núm. 21, pp. 4320-4322
-
ENPP1 Immunobiology as a Therapeutic Target
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 12, pp. 2184-2193
-
Futuro y líneas de investigación clínica del cáncer de mama triple negativo avanzado
Revisiones en Cancer, Vol. 37, Núm. 1, pp. 17-29
-
Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery
Clinical and Translational Oncology, Vol. 25, Núm. 8, pp. 2523-2531
-
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
Journal for immunotherapy of cancer, Vol. 11, Núm. 1
-
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity
Cancer immunology research, Vol. 11, Núm. 2, pp. 184-198